Amdocs Limited (NASDAQ:DOX) Short Interest Up 9.5% in April

Amdocs Limited (NASDAQ:DOX) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 2,070,000 shares, a growth of 9.5% from the March 31st total of 1,890,000 shares. Based on an average daily trading volume, of 673,100 shares, the short-interest ratio is presently 3.1 days. Currently, 1.8% of the shares of the company are short sold.

Wall Street Analysts Forecast Growth

DOX has been the subject of several research reports. StockNews.com downgraded Amdocs from a “strong-buy” rating to a “buy” rating in a report on Friday, March 15th. Citigroup increased their price target on shares of Amdocs from $96.00 to $104.00 and gave the company a “buy” rating in a report on Wednesday, January 17th. Finally, Barclays boosted their price objective on shares of Amdocs from $105.00 to $115.00 and gave the company an “overweight” rating in a report on Thursday, February 8th. Five analysts have rated the stock with a buy rating, According to MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $108.60.

Amdocs Stock Down 0.1 %

Shares of NASDAQ DOX opened at $84.87 on Tuesday. The stock has a market capitalization of $9.98 billion, a P/E ratio of 18.17, a PEG ratio of 1.38 and a beta of 0.69. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.29 and a current ratio of 1.29. Amdocs has a 52 week low of $78.38 and a 52 week high of $99.75. The stock’s fifty day moving average is $89.50 and its 200 day moving average is $87.41.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings data on Tuesday, February 6th. The technology company reported $1.56 EPS for the quarter, beating the consensus estimate of $1.40 by $0.16. Amdocs had a net margin of 11.30% and a return on equity of 17.79%. The business had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.24 billion. During the same period in the previous year, the business earned $1.33 earnings per share. The company’s revenue was up 5.0% on a year-over-year basis. Sell-side analysts forecast that Amdocs will post 5.87 earnings per share for the current fiscal year.

Amdocs Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, April 26th. Stockholders of record on Friday, March 29th were paid a $0.479 dividend. This is an increase from Amdocs’s previous quarterly dividend of $0.44. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.26%. The ex-dividend date of this dividend was Wednesday, March 27th. Amdocs’s dividend payout ratio (DPR) is presently 41.11%.

Institutional Investors Weigh In On Amdocs

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Financiere des Professionnels Fonds d investissement inc. boosted its position in Amdocs by 1.3% during the 4th quarter. Financiere des Professionnels Fonds d investissement inc. now owns 9,790 shares of the technology company’s stock worth $860,000 after buying an additional 130 shares during the period. New York State Teachers Retirement System grew its stake in shares of Amdocs by 1.3% in the first quarter. New York State Teachers Retirement System now owns 10,719 shares of the technology company’s stock worth $969,000 after purchasing an additional 141 shares during the last quarter. First Eagle Investment Management LLC increased its holdings in Amdocs by 6.3% in the third quarter. First Eagle Investment Management LLC now owns 2,448 shares of the technology company’s stock valued at $207,000 after purchasing an additional 145 shares during the period. CI Investments Inc. raised its position in Amdocs by 0.7% during the 3rd quarter. CI Investments Inc. now owns 21,000 shares of the technology company’s stock worth $1,774,000 after purchasing an additional 152 shares during the last quarter. Finally, Balentine LLC grew its position in shares of Amdocs by 5.3% in the 3rd quarter. Balentine LLC now owns 3,050 shares of the technology company’s stock valued at $258,000 after buying an additional 153 shares during the last quarter. 92.02% of the stock is owned by institutional investors.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.